Literature DB >> 7900408

Use of proton nmr spectroscopy to measure propofol metabolites in the urine of the female Caucasian patient.

J R Sneyd1, P J Simons, B Wright.   

Abstract

1. Six female Caucasian patients received i.v. doses of propofol (2.7 +/- 0.3 (SE) mg/kg) for induction of anaesthesia. Anaesthesia was maintained with nitrous oxide, oxygen and enflurane for periods up to 3 h. A total urine collection was made from each subject for 24 h after administration of propofol; samples were concentrated and analysed for propofol metabolites by nmr spectroscopy. 2. By 24 h, 50.9 +/- 4.0% of the dose of propofol was recovered as metabolites. The proportions of propofol metabolites, 1-quinol glucuronide (1-QG), 4-quinol glucuronide (4-QG), propofol glucuronide (PG) and 4-quinol sulphate (4-QS) recovered in urine (0-24 h) of the patients were 12 +/- 1, 8 +/- 2, 76 +/- 4 and 4 +/- 1% respectively. However, one patient showed a metabolite profile in which PG comprised 93% and 1-QG 7% of the total metabolites. 3. Nmr spectroscopy has been shown to be a satisfactory method for the quantification of propofol metabolites in urine without the necessity for reference samples.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7900408     DOI: 10.3109/00498259409043299

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  6 in total

1.  Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia.

Authors:  Irena Loryan; Marja Lindqvist; Inger Johansson; Masahiro Hiratsuka; Ilse van der Heiden; Ron H N van Schaik; Jan Jakobsson; Magnus Ingelman-Sundberg
Journal:  Eur J Clin Pharmacol       Date:  2011-10-18       Impact factor: 2.953

2.  Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain.

Authors:  Haruhiko Hiraoka; Koujirou Yamamoto; Soutarou Miyoshi; Toshihiro Morita; Katsunori Nakamura; Yuuji Kadoi; Fumio Kunimoto; Ryuya Horiuchi
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

3.  Urinary metabolites after intravenous propofol bolus in neonates.

Authors:  Anne Smits; Rene Verbesselt; Aida Kulo; Gunnar Naulaers; Jan de Hoon; Karel Allegaert
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-11-17       Impact factor: 2.441

Review 4.  Neonatal clinical pharmacology.

Authors:  Karel Allegaert; Marc van de Velde; John van den Anker
Journal:  Paediatr Anaesth       Date:  2013-04-26       Impact factor: 2.556

5.  Premedication medicines do not cause drug metabolic interaction with propofol using human liver microsomes in vitro.

Authors:  Einosuke Tanaka; Yui Takano; Shinichi Inomata; Hidenori Toyooka; Katsuya Honda
Journal:  Eur J Clin Pharmacol       Date:  2004-09-04       Impact factor: 2.953

6.  Green discoloration of urine after propofol infusion.

Authors:  Jung-Sam Lee; Hyun-Soo Jang; Byeong-Jae Park
Journal:  Korean J Anesthesiol       Date:  2013-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.